Hepatology

Testing for elevated liver enzymes should be deliberate and focused, as limited testing can save time and money and prevent false positives.

The American College of Gastroenterology recently released new guidelines, the first in 10 years, on the evaluation of abnormal liver chemistries.

A new study extended the period of treatment for patients with Hepatitis C on Sofosbuvir and Ribavirin to test whether SVF12 rates can be attained in real-life.

Researchers assessed direct-acting antiviral agents and availability of funding to determine the impact on ability to treat and cure veterans with hepatitis C virus.

A fixed dose of elbasvir-grazoprevir, with or without ribavirin, is well tolerated in patients with hepatitis C virus genotypes 1, 4, or 6.

A new study assessed the impact of treatment status on the risk of hepatocellular carcinoma in patients with hepatitis C virus.

A recent study aimed to determine the impact of treatment adherence to sofosbuvir-based regimens on virological outcomes in patients with hepatitis C virus.

Research discussed at an international symposium suggests that treating people who use drugs and have hepatitis C virus can reduce the prevalence of the infection. However, barriers prevent this population...

A new test uses urine samples rather than blood to detect infection with the hepatitis C virus.

Two recent studies examined the effects on sustained virologic response rates in patients with genotypes 1-6 hepatitis C virus infection treated with sofosbuvir and velpatasvir.